Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|February 8, 2017
Bile acid disease: the emerging epidemicIbironke Oduyebo, Michael Camilleri
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 10, 2016
Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questionsMichael Camilleri, Ibironke Oduyebo, Houssam Halawi
Expert Review of Gastroenterology & Hepatology|January 28, 2017
Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Michael Camilleri, Houssam Halawi, Ibironke Oduyebo
Surgical Endoscopy|December 11, 2014
Choledochal or pancreatic cyst? Role of endoscopic ultrasound as an adjunct for diagnosis: a case seriesIbironke Oduyebo, Joanna K Law, Atif Zaheer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 5, 2017
Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in healthHoussam Halawi, Michael Camilleri, Andres Acosta, et al.
Journal of Hospital Medicine|June 3, 2017
Does Provider Self-Reporting of Etiquette Behaviors Improve Patient Experience? A Randomized Controlled TrialZishan Siddiqui, Rehan Qayyum, Amanda Bertram, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 18, 2017
Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitantDeepti Jacob, Irene Busciglio, Duane Burton, et al.
JAMA Internal Medicine|March 27, 2013
Association of self-reported hospital discharge handoffs with 30-day readmissionsIbironke Oduyebo, Christoph U Lehmann, Craig Evan Pollack, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2020
Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoeaMichael Camilleri, Sara Linker Nord, Duane Burton, et al.
The American Journal of Gastroenterology|May 3, 2018
Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trialIbironke Oduyebo, Michael Camilleri, Alfred D Nelson, et al.
Pageof 1